Page 2 - Budding Trends News Today

I’m not proud of it, but I’m the resident cynic amongst the editorial staff here at Budding Trends when it comes to federal marijuana reform. And after all, someone has to temper the...

FDA issued warning letters on November 21 that may signal a shift in enforcement posture away from solely targeting companies that market CBD as a potential medical treatment and towards including companies that market their products in ways that could cause consumer confusion.

FDA warning letters are nothing new in the cannabis industry. In fact, we here at Budding Trends have covered this topic a number of times (here, here, and here). Not resigned to...

As a growing number of patients are procuring their registration cards to participate in Mississippi’s medical cannabis program, approximately 50

After midterm elections we ended up with same balance of power in Senate, small Republican majority in House. Since outgoing Congress has not passed meaningful federal cannabis reform, status quo seems like bad news, but there are two reasons to be optimistic.